From the 18 genes they validated by real-time polymerase chain reaction, four (MMP11, PLAU, BGN, and FAP) are also present in our filtered data sets of significantly regulated probe sets comparing DCIS and invasive samples. Here, BGN is linked to ductal breast carcinoma in situ.